New board to improve internal oversight, consumer communication of drug safety issues


The new independent Drug Safety Oversight Board (DSB) within CDER will employ a two-pronged approach to create "a new culture of openness, improved oversight, and enhanced independence," according to FDA officials.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.